Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation in Exacerbation of Chronic Obstructive Pulmonary Disease

References

• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
   PubMed Web of Science ®Google Scholar
• Venkatesan P. GOLD COPD report: 2023 update. Lancet Respir Med. 2023;11(1):18. doi:10.1016/s2213-2600(22)00494-5
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/s0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• World Health Organization. The top 10 causes of death. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed June 5, 2023.
   Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/s0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.847
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422. doi:10.1164/ajrccm.157.5.9709032
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Ko FW, Chan KP, Hui DS, et al. Acute exacerbation of COPD. Respirology. 2016;21(7):1152–1165. doi:10.1111/resp.12780
   PubMed Web of Science ®Google Scholar
• Walters JA, Tan DJ, White CJ, Gibson PG, Wood-Baker R, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;9:Cd001288. doi:10.1002/14651858.CD001288.pub4
   Web of Science ®Google Scholar
• Sayiner A, Aytemur ZA, Cirit M, Unsal İ. Systemic glucocorticoids in severe exacerbations of COPD. Chest. 2001;119(3):726–730. doi:10.1378/chest.119.3.726
   PubMed Web of Science ®Google Scholar
• Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550–559. doi:10.1038/s41590-021-00886-5
   PubMed Web of Science ®Google Scholar
• Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance. J Cell Sci. 2017;130(23):3955–3963. doi:10.1242/jcs.207365
   PubMed Web of Science ®Google Scholar
• Proell M, Gerlic M, Mace PD, Reed JC, Riedl SJ. The CARD plays a critical role in ASC foci formation and inflammasome signalling. Biochem J. 2013;449(3):613–621. doi:10.1042/bj20121198
   PubMedGoogle Scholar
• Colarusso C, Terlizzi M, Molino A, Pinto A, Sorrentino R. Role of the inflammasome in chronic obstructive pulmonary disease (COPD). Oncotarget. 2017;8(47):81813–81824. doi:10.18632/oncotarget.17850
   PubMedGoogle Scholar
• Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397–411. doi:10.1038/nri3452
   PubMed Web of Science ®Google Scholar
• Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008;223:20–38. doi:10.1111/j.1600-065X.2008.00624.x
   PubMed Web of Science ®Google Scholar
• Wang H, Lv C, Wang S, Ying H, Weng Y, Yu W. NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease. Inflammation. 2018;41(4):1321–1333. doi:10.1007/s10753-018-0780-0
   PubMed Web of Science ®Google Scholar
• Li M, Hua Q, Shao Y, et al. Circular RNA circBbs9 promotes PM(2.5)-induced lung inflammation in mice via NLRP3 inflammasome activation. Environ Int. 2020;143:105976. doi:10.1016/j.envint.2020.105976
   PubMed Web of Science ®Google Scholar
• Nachmias N, Langier S, Brzezinski RY, et al. NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation. PLoS One. 2019;14(5):e0214622. doi:10.1371/journal.pone.0214622
   PubMed Web of Science ®Google Scholar
• Faner R, Sobradillo P, Noguera A, et al. The inflammasome pathway in stable COPD and acute exacerbations. ERJ Open Res. 2016;2(3). doi:10.1183/23120541.00002-2016
   PubMedGoogle Scholar
• Ji S, Dai MY, Huang Y, et al. Influenza a virus triggers acute exacerbation of chronic obstructive pulmonary disease by increasing proinflammatory cytokines secretion via NLRP3 inflammasome activation. J Inflamm. 2022;19(1):8. doi:10.1186/s12950-022-00305-y
   Google Scholar
• Zhang J, Xu Q, Sun W, Zhou X, Fu D, Mao L. New insights into the role of NLRP3 inflammasome in pathogenesis and treatment of chronic obstructive pulmonary disease. J Inflamm Res. 2021;14:4155–4168. doi:10.2147/jir.S324323
   PubMed Web of Science ®Google Scholar
• Akbar S. Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern Med Rev. 2011;16(1):66–77.
   PubMedGoogle Scholar
• Lim JC, Chan TK, Ng DS, Sagineedu SR, Stanslas J, Wong WS. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin Exp Pharmacol Physiol. 2012;39(3):300–310. doi:10.1111/j.1440-1681.2011.05633.x
   PubMed Web of Science ®Google Scholar
• Tan WSD, Liao W, Zhou S, Wong WSF. Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochem Pharmacol. 2017;139:71–81. doi:10.1016/j.bcp.2017.03.024
   PubMed Web of Science ®Google Scholar
• Ding Y, Chen L, Wu W, Yang J, Yang Z, Liu S. Andrographolide inhibits influenza A virus-induced inflammation in a murine model through NF-κB and JAK-STAT signaling pathway. Microbes Infect. 2017;19(12):605–615. doi:10.1016/j.micinf.2017.08.009
   PubMed Web of Science ®Google Scholar
• Li J, Luo L, Wang X, Liao B, Li G. Inhibition of NF-kappaB expression and allergen-induced airway inflammation in a mouse allergic asthma model by andrographolide. Cell Mol Immunol. 2009;6(5):381–385. doi:10.1038/cmi.2009.49
   PubMed Web of Science ®Google Scholar
• Duan MX, Zhou H, Wu QQ, et al. Andrographolide protects against HG-induced inflammation, apoptosis, migration, and impairment of angiogenesis via PI3K/AKT-eNOS signalling in HUVECs. Mediators Inflamm. 2019;2019:6168340. doi:10.1155/2019/6168340
   PubMed Web of Science ®Google Scholar
• Wong SY, Tan MG, Wong PT, Herr DR, Lai MK. Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK. J Neuroinflammation. 2016;13(1):251. doi:10.1186/s12974-016-0723-3
   PubMedGoogle Scholar
• Yen CC, Lii CK, Chen CC, et al. Andrographolide inhibits lipotoxicity-induced activation of the NLRP3 inflammasome in bone marrow-derived macrophages. Am J Chin Med. 2023;51(1):129–147. doi:10.1142/s0192415x23500088
   PubMedGoogle Scholar
• He W, Sun J, Zhang Q, et al. Andrographolide exerts anti-inflammatory effects in Mycobacterium tuberculosis-infected macrophages by regulating the Notch1/Akt/NF-κB axis. J Leukoc Biol. 2020;108(6):1747–1764. doi:10.1002/jlb.3ma1119-584rrr
   PubMed Web of Science ®Google Scholar
• Zhang XF, Ding MJ, Cheng C, et al. Andrographolide attenuates oxidative stress injury in cigarette smoke extract exposed macrophages through inhibiting SIRT1/ERK signaling. Int Immunopharmacol. 2020;81:106230. doi:10.1016/j.intimp.2020.106230
   PubMed Web of Science ®Google Scholar
• Tan WS, Peh HY, Liao W, et al. Cigarette smoke-induced lung disease predisposes to more severe infection with nontypeable Haemophilus influenzae: protective effects of andrographolide. J Nat Prod. 2016;79(5):1308–1315. doi:10.1021/acs.jnatprod.5b01006
   PubMed Web of Science ®Google Scholar
• Barrett EG, Wilder JA, March TH, Espindola T, Bice DE. Cigarette smoke-induced airway hyperresponsiveness is not dependent on elevated immunoglobulin and eosinophilic inflammation in a mouse model of allergic airway disease. Am J Respir Crit Care Med. 2002;165(10):1410–1418. doi:10.1164/rccm.2106029
   PubMed Web of Science ®Google Scholar
• Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM. Inflammasomes in COPD and neutrophilic asthma. Thorax. 2015;70(12):1199–1201. doi:10.1136/thoraxjnl-2014-206736
   PubMed Web of Science ®Google Scholar
• Leszczyńska K, Jakubczyk D, Górska S. The NLRP3 inflammasome as a new target in respiratory disorders treatment. Front Immunol. 2022;13:1006654. doi:10.3389/fimmu.2022.1006654
   PubMed Web of Science ®Google Scholar
• Ma Y, Long Y, Chen Y. Roles of inflammasome in cigarette smoke-related diseases and physiopathological disorders: mechanisms and therapeutic opportunities. Front Immunol. 2021;12:720049. doi:10.3389/fimmu.2021.720049
   PubMed Web of Science ®Google Scholar
• Ji S, Bai Q, Wu X, et al. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease. Biomed Pharmacother. 2020;121:109652. doi:10.1016/j.biopha.2019.109652
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671. doi:10.1164/rccm.201104-0597OC
   PubMed Web of Science ®Google Scholar
• Fu JJ, McDonald VM, Baines KJ, Gibson PG. Airway IL-1β and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest. 2015;148(3):618–629. doi:10.1378/chest.14-2337
   PubMed Web of Science ®Google Scholar
• Zou Y, Chen X, Liu J, et al. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters. Int J Chron Obstruct Pulmon Dis. 2017;12:1247–1254. doi:10.2147/copd.S131877
   PubMed Web of Science ®Google Scholar
• Churg A, Zhou S, Wang X, Wang R, Wright JL. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol. 2009;40(4):482–490. doi:10.1165/rcmb.2008-0038OC
   PubMed Web of Science ®Google Scholar
• Doz E, Noulin N, Boichot E, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol. 2008;180(2):1169–1178. doi:10.4049/jimmunol.180.2.1169
   PubMed Web of Science ®Google Scholar
• Zhong Y, Kinio A, Saleh M. Functions of NOD-like receptors in human diseases. Front Immunol. 2013;4:333. doi:10.3389/fimmu.2013.00333
   PubMed Web of Science ®Google Scholar
• Akata K, van Eeden SF. Lung macrophage functional properties in chronic obstructive pulmonary disease. Int J Mol Sci. 2020;21(3). doi:10.3390/ijms21030853
   PubMed Web of Science ®Google Scholar
• Lee JW, Chun W, Lee HJ, et al. The role of macrophages in the development of acute and chronic inflammatory lung diseases. Cells. 2021;10(4). doi:10.3390/cells10040897
   Web of Science ®Google Scholar
• Chen X, Tang J, Shuai W, Meng J, Feng J, Han Z. Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome. Inflamm Res. 2020;69(9):883–895. doi:10.1007/s00011-020-01378-2
   PubMed Web of Science ®Google Scholar
• Aggarwal NR, King LS, D’Alessio FR. Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol. 2014;306(8):L709–25. doi:10.1152/ajplung.00341.2013
   PubMed Web of Science ®Google Scholar
• Hayman YA, Sadofsky LR, Williamson JD, Hart SP, Morice AH. The effects of exogenous lipid on THP-1 cells: an in vitro model of airway aspiration? ERJ Open Res. 2017;3(1). doi:10.1183/23120541.00026-2016
   PubMedGoogle Scholar
• Heulens N, Korf H, Mathyssen C, et al. 1,25-Dihydroxyvitamin D modulates antibacterial and inflammatory response in human cigarette smoke-exposed macrophages. PLoS One. 2016;11(8):e0160482. doi:10.1371/journal.pone.0160482
   PubMed Web of Science ®Google Scholar
• Liu C, Wang M, Sun W, et al. PU.1 serves a critical role in the innate defense against Aspergillus fumigatus via dendritic cell-associated C-type lectin receptor-1 and toll-like receptors-2 and 4 in THP-1-derived macrophages. Mol Med Rep. 2017;15(6):4084–4092. doi:10.3892/mmr.2017.6504
   PubMed Web of Science ®Google Scholar
• Kumar H, Kumagai Y, Tsuchida T, et al. Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J Immunol. 2009;183(12):8061–8067. doi:10.4049/jimmunol.0902477
   PubMed Web of Science ®Google Scholar
• McNeela EA, Burke A, Neill DR, et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 2010;6(11):e1001191. doi:10.1371/journal.ppat.1001191
   PubMed Web of Science ®Google Scholar
• Rotta Detto Loria J, Rohmann K, Droemann D, et al. Nontypeable Haemophilus influenzae infection upregulates the NLRP3 inflammasome and leads to Caspase-1-dependent secretion of Interleukin-1β - a possible pathway of exacerbations in COPD. PLoS One. 2013;8(6):e66818. doi:10.1371/journal.pone.0066818
   PubMed Web of Science ®Google Scholar
• Tate MD, Ong JDH, Dowling JK, et al. Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition. Sci Rep. 2016;6:27912. doi:10.1038/srep27912
   PubMed Web of Science ®Google Scholar
• Płóciennikowska A, Hromada-Judycka A, Borzęcka K, Kwiatkowska K. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2015;72(3):557–581. doi:10.1007/s00018-014-1762-5
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13). doi:10.3390/ijms20133328
   PubMed Web of Science ®Google Scholar
• Cao Y, Zhou X, Yin Z, et al. The anti-inflammatory effect of BML-111 on COPD may be mediated by regulating NLRP3 inflammasome activation and ROS production. Prostaglandins Other Lipid Mediat. 2018;138:23–30. doi:10.1016/j.prostaglandins.2018.08.001
   PubMed Web of Science ®Google Scholar
• Mahalanobish S, Dutta S, Saha S, Sil PC. Melatonin induced suppression of ER stress and mitochondrial dysfunction inhibited NLRP3 inflammasome activation in COPD mice. Food Chem Toxicol. 2020;144:111588. doi:10.1016/j.fct.2020.111588
   PubMed Web of Science ®Google Scholar
• Peng Z, Zhang W, Qiao J, He B. Melatonin attenuates airway inflammation via SIRT1 dependent inhibition of NLRP3 inflammasome and IL-1β in rats with COPD. Int Immunopharmacol. 2018;62:23–28. doi:10.1016/j.intimp.2018.06.033
   PubMed Web of Science ®Google Scholar
• Tian Q, Xu M, He B. Histidine ameliorates elastase- and lipopolysaccharide-induced lung inflammation by inhibiting the activation of the NLRP3 inflammasome. Acta Biochim Biophys Sin. 2021;53(8):1055–1064. doi:10.1093/abbs/gmab072
   Google Scholar
• Tian X, Xue Y, Xie G, et al. (-)-Epicatechin ameliorates cigarette smoke-induced lung inflammation via inhibiting ROS/NLRP3 inflammasome pathway in rats with COPD. Toxicol Appl Pharmacol. 2021;429:115674. doi:10.1016/j.taap.2021.115674
   PubMed Web of Science ®Google Scholar
• Wang L, Chen Q, Yu Q, Xiao J, Zhao H. TREM-1 aggravates chronic obstructive pulmonary disease development via activation NLRP3 inflammasome-mediated pyroptosis. Inflamm Res. 2021;70(9):971–980. doi:10.1007/s00011-021-01490-x
   PubMed Web of Science ®Google Scholar
• Wang L, Lei W, Zhang S, Yao L. MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice. Bioorg Med Chem. 2021;30:115954. doi:10.1016/j.bmc.2020.115954
   PubMed Web of Science ®Google Scholar
• Zhang MY, Jiang YX, Yang YC, et al. Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS/NLRP3/caspase-1 pathway. Life Sci. 2021;269:119090. doi:10.1016/j.lfs.2021.119090
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Sethi S, Dawson M, et al. A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease. Respir Res. 2017;18(1):153. doi:10.1186/s12931-017-0633-7
   PubMedGoogle Scholar
• MedImmune. A study to evaluate the safety of MEDI2338 in subjects with chronic obstructive pulmonary disease. Available from: https://clinicaltrials.gov/ct2/show/NCT01322594. Accessed May 16, 2024.
   Google Scholar
• Novartis. Safety And efficacy of multiple doses of canakinumab (ACZ885) in chronic obstructive pulmonary disease (COPD) patients. Available from: https://clinicaltrials.gov/ct2/show/NCT00581945. Accessed May 16, 2024.
   Google Scholar
• Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21(3):248–255. doi:10.1038/nm.3806
   PubMed Web of Science ®Google Scholar
• Madurka I, Vishnevsky A, Soriano JB, et al. DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function. Infection. 2023;51(3):641–654. doi:10.1007/s15010-022-01904-w
   PubMed Web of Science ®Google Scholar
• Islam MT, Ali ES, Uddin SJ, et al. Andrographolide, a diterpene lactone from Andrographis paniculata and its therapeutic promises in cancer. Cancer Lett. 2018;420:129–145. doi:10.1016/j.canlet.2018.01.074
   PubMed Web of Science ®Google Scholar
• Li J, Xie Y, Zhao P, et al. A Chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38. Phytomedicine. 2021;83:153475. doi:10.1016/j.phymed.2021.153475
   PubMed Web of Science ®Google Scholar
• Tao L, Lu X, Fu Z, et al. Tong Sai granule improves AECOPD via regulation of MAPK-SIRT1-NF-κB pathway and cellular senescence alleviation. J Ethnopharmacol. 2023;314:116622. doi:10.1016/j.jep.2023.116622
   PubMed Web of Science ®Google Scholar
• Lu F, Yang H, Lin SD, et al. Cyclic peptide extracts derived from Pseudostellaria heterophylla ameliorates COPD via regulation of the TLR4/MyD88 pathway proteins. Front Pharmacol. 2020;11:850. doi:10.3389/fphar.2020.00850
   PubMed Web of Science ®Google Scholar
• Pinzi L, Rastelli G. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019;20(18):4331. doi:10.3390/ijms20184331
   PubMed Web of Science ®Google Scholar